Used as an intermediate in the synthesis of pharmaceuticals, particularly in the development of central nervous system agents and anti-inflammatory compounds. Its structure allows for modification in drug design, making it valuable in creating analogs with enhanced biological activity. Commonly employed in organic synthesis to introduce the 4-bromophenylcyclopentyl moiety, which can influence receptor binding and metabolic stability in active pharmaceutical ingredients.